AMICUS THERAPEUTICS, INC.
Biotechnology · Healthcare
Jeffrey P. Castelli
Equibles does not estimate personal net worth.
About Jeffrey P. Castelli
AMICUS THERAPEUTICS, INC. reported in an 8-K filed April 27, 2026 that Jeffrey P. Castelli resigned as executive officer, effective April 27, 2026. The proxy statement of AMICUS THERAPEUTICS, INC. reports total compensation of $3,442,896 for Jeffrey P. Castelli in fiscal 2024, including a base salary of $491,807. Disclosed compensation is on record for 3 fiscal years.
“In connection with the consummation of the Merger, as of the Effective Time, all executive officers of the Company immediately prior to the Effective Time (Bradley L. Campbell, Simon Harford, Ellen S. Rosenberg, David M. Clark and Jeffrey P. Castelli) ceased to be executive officers of the Surviving Corporation.”
Affiliation history
-
AMICUS THERAPEUTICS, INC.
Proxy statement
Start not stated–2026-04-27
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | AMICUS THERAPEUTICS, INC. | Chief Development Officer | $491,807 | $3,442,896 |
| 2023 | AMICUS THERAPEUTICS, INC. | Chief Development Officer | $464,721 | $3,671,762 |
| 2022 | AMICUS THERAPEUTICS, INC. | Chief Development Officer | $451,025 | $3,055,703 |